Fiseha M Gebregiorgis, PAC | |
1225 Hancock Rd, Suite C, Bullhead City, AZ 86442-5948 | |
(928) 758-0121 | |
(928) 758-0145 |
Full Name | Fiseha M Gebregiorgis |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Experience | 14 Years |
Location | 1225 Hancock Rd, Bullhead City, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245525344 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | 4866 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Adventist Healthcare Shady Grove Medical Center | Rockville, MD | Hospital |
Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mep Observation Services Llc | 2365611845 | 36 |
Usacs Integrated Acute Care Services Of Maryland Llc | 4486900172 | 218 |
News Archive
Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today the acquisition of the world's largest cryo-preserved human cancer tissue bank—more than 144,000 specimens procured over 20 years. The company acquired the tumor bank, along with properly de-identified clinical information and validated test procedures, as part of a major acquisition of key assets formerly owned by Oncotech.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced data from a subgroup analysis of a Phase 2 randomized discontinuation trial showing that the median progression-free survival (PFS) achieved by patients with advanced clear cell renal cell carcinoma (RCC) who had undergone a prior nephrectomy was 14.8 months.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the PATH Malaria Vaccine Initiative (MVI) has agreed to provide follow-on funding to continue evaluation and development of Inovio's malaria DNA vaccine candidate in non-human primates.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and others proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, today announced financial results for the first quarter ended March 31, 2014.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Fiseha M Gebregiorgis, PAC 1225 Hancock Rd, Suite C, Bullhead City, AZ 86442-5948 Ph: (928) 758-0121 | Fiseha M Gebregiorgis, PAC 1225 Hancock Rd, Suite C, Bullhead City, AZ 86442-5948 Ph: (928) 758-0121 |
News Archive
Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today the acquisition of the world's largest cryo-preserved human cancer tissue bank—more than 144,000 specimens procured over 20 years. The company acquired the tumor bank, along with properly de-identified clinical information and validated test procedures, as part of a major acquisition of key assets formerly owned by Oncotech.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced data from a subgroup analysis of a Phase 2 randomized discontinuation trial showing that the median progression-free survival (PFS) achieved by patients with advanced clear cell renal cell carcinoma (RCC) who had undergone a prior nephrectomy was 14.8 months.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the PATH Malaria Vaccine Initiative (MVI) has agreed to provide follow-on funding to continue evaluation and development of Inovio's malaria DNA vaccine candidate in non-human primates.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and others proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, today announced financial results for the first quarter ended March 31, 2014.
› Verified 7 days ago
Kitrin Lance Carpenter, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 967 Hancock Rd Ste 133, Bullhead City, AZ 86442 Phone: 928-224-0064 Fax: 480-842-8608 | |
Minnie A Mercer, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1355 Ramar Rd Ste 11, Bullhead City, AZ 86442 Phone: 928-704-9202 Fax: 928-704-9207 | |
Larry Joseph Keating, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3003 Highway 95, Suite G73, Bullhead City, AZ 86442 Phone: 928-758-7700 Fax: 928-758-5700 | |
Eric Fergen, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1355 Ramar Rd Ste 11, Bullhead City, AZ 86442 Phone: 928-704-9202 Fax: 928-704-9207 | |
Darlene M Leftwich, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1355 Ramar Rd, Bullhead City, AZ 86442 Phone: 928-704-9202 Fax: 928-704-9207 | |
Randy Chadwell, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Canyon Rd Bldg B, Bullhead City, AZ 86442 Phone: 928-444-1491 Fax: 435-787-1913 |